Key figures

A nationwide network for greater proximity

18 French Comprehensive Cancer Centres

20 hospital sites

20 000+ employees 

A highly qualified and specialised team

 516 000 patients every year

1 215 000 consults

2.4 billion Euros

of total profit

In France, the French Comprehensive Cancer Centres treat
30% of women with breast cancer
21% of people with an endocrine tumor
20% of women with gynaecological cancers

Data from 2017 unless noted otherwise

Quality of care

French health authorities, such as the French National Cancer Institute (INCa) and the Ministry of Health, have recognized the quality of care in the Unicancer network, through various certifications:

7    expert centres and networks for rare cancers in adults
15 certified centres for paediatric cancers (out of 47, in France)
6    centres for cancers in teenagers and young adults
16 oncogeriatrics centres
12 oncogenetic laboratories certified by the French National Cancer Institute (out of 25)

State-of-the-art equipment

Innovative facilities including protontherapy centres, Cyberknife, Intrabeam and tomotherapy

A state-of-the-art technical platform

Clinical research, an opportunity for patients

569  active clinical trials, promoted by the FCCCs and Unicancer R&D
15% of patients in clinical trials, exceeding the 10% target set by the second French cancer plan

The French health authorities, such as the French National Cancer Institute (INCa) and the Ministry of Health, have recognized the quality of research in the Unicancer network, through various certifications:
12 early trial centres (CLIP2) certified by the French National Cancer Institute, out of 16 en France
20 oncology clinical research hospital programmes (PHRC), out of 39 in France
6  cancer integrated research sites (SIRIC), out of 8 in France

Data from 2017 unless noted otherwise